LBA56 MEDI5752 or pembrolizumab (P) plus carboplatin/pemetrexed (CP) in treatment-naïve (1L) non-small cell lung cancer (NSCLC): A phase Ib/II trial
| Autor: | Ahn, M-J., Kim, S-W., Costa, E. Carcereny, Rodríguez, L.M., Oliveira, J., Insa Molla, M.A., Majem, M., Costa, L., Su, W-C., Lee, K.H., Yang, J.C-H., Spigel, D.R., Cho, E.K., D'Arcangelo, M., Campelo, M.R. Garcia, Delmonte, A., Mitchell, P., Achour, I., Subramaniam, D., Felip, E. |
|---|---|
| Zdroj: | In Annals of Oncology September 2022 33 Supplement 7:S1423-S1423 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|